Quantcast

IntelligentM Targets Deadly, Costly Hospital-Acquired Infections at U.S. Medical Facilities

April 16, 2013

Significant Mortality and Billions in Costs From Patient Infections Contracted by Improper Employee Hand Hygiene at U.S. Hospitals

WASHINGTON, D.C. (PRWEB) April 16, 2013

IntelligentM today announced it has contracted with multiple hospitals for the use of its unique IntelligentM Smartband System, which combats improper hand hygiene that results in tens of thousands of annual deaths and billions of dollars in unnecessary costs to the U.S. hospital system.

The current hand hygiene compliance rate for U.S. hospitals is about 40 percent, providing significant room for improvement and the basis of IntelligentM´s business model (1). In a typical hospital the company´s Smartbands, worn by healthcare workers that have direct contact with patients, interact with RFID and Bluetooth tags on sanitizer dispensers, soap dispensers, and on equipment and products, such as IV and catheter packaging. The IntelligentM System is able to provide on-the-spot notification of non-compliant hand hygiene events for both “how” healthcare workers perform hand washing and sanitizing, as well as “when” they should be washing/sanitizing. This includes the never before offered ability to tie hand hygiene compliance to specific infection types, like central line-associated bloodstream infections (CLABSI) and catheter-associated urinary tract infections (CAUTI) — two of the most common and most costly infections for hospitals. The Smartbands vibrate once for a compliant hand washing/sanitizing and three times for a non-compliant event.

“Infections with antibiotic-resistant bacteria such as MRSA, which are difficult to treat, are often transmitted by the contaminated hands of healthcare providers who have touched a colonized patient or something in the patient’s environment,” said Leah Frederick, MS, RN, CIC and owner of Infection Prevention Consultants, LLC. “Caregivers who leave the bedsides of such patients without performing correct hand hygiene may carry thousands or even hundreds of thousands of colony-forming units of antibiotic-resistant bacteria on their hands.”

In addition to the human cost of infections in death and suffering, the monetary cost is devastating the U.S. healthcare system, increasing the average stay for a patient that acquires one of these infections by 17 days and costing billions of dollars (2). IntelligentM´s system is cost-effective, with the total annual break even amount for a hospital to install and operate it equal to the cost of about one MRSA infection case or three CLABSI cases per year. A typical hospital realizes dozens of CLABSI cases per year. The system is simple for IntelligentM to install, as it does not connect to the hospital´s IT system nor need to leverage a WiFi network to operate.

“Much of the public doesn´t realize that acquiring infections from improper staff hand hygiene in hospitals is a very prevalent and serious issue,” said Seth Freedman, president, IntelligentM. “We are the first company to provide a system that immediately alerts hospital staff when they are not properly washing their hands, enabling on-the-spot correction, and does so based on the Centers for Disease Control and World Health Organization hygiene specifications for the task being performed. It also gives hospitals a tremendous amount of segmented data on hand hygiene performance critical to further the reduction of infection rates.”

IntelligentM has received significant attention in the healthcare sector in a brief period of time, having just been named one of only 13 companies by General Electric (GE Healthymagination) and StartUp Health selected for a three-year program to accelerate growth for consumer health companies. More than 400 companies from 22 countries applied for the program.

“Healthcare worker hand hygiene is a critical issue for hospitals nationwide,” said Michele Barr, RN, BSN, CIC with CIP Consulting, LLC. “Healthcare institutions must continue to make progress in their infection prevention processes to prevent adverse patient outcomes.”

In addition to the U.S. market, IntelligentM is certified for sale in the European Union, Australia and the Far East, and expects to enter these markets soon. The company´s technology also has applications beyond the health sector, such as in food service.

Visit http://www.intelligentm.com for more information about the company and view the animation for a depiction of the infection problem in U.S. hospitals and IntelligentM´s solution.

IntelligentM made today´s announcement at TEDMED 2013, a multi-disciplinary community of innovators and leaders who share a common determination to create a better future in health and medicine. The conference is being held in Washington, D.C., April 16-19.

###

1) McGuckin M, Waterman R, Govednik J., American Journal of Medical Quality, http://www.ncbi.nlm.nih.gov/pubmed/19332864

2) Deoine Reed, PhD and Sandra A. Kemmerly, MD., The Ochsner Journal, http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096239/

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2013/4/prweb10635781.htm


Source: prweb



comments powered by Disqus